СТРАТИФИКАЦИЯ РИСКА ПРОГРЕССИРОВАНИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ И ВОЗМОЖНОСТИ ВТОРИЧНОЙ ПРОФИЛАКТИКИ
Аннотация
Прогрессирование фибрилляции предсердий (ФП) – это процесс неуклонного развития аритмии от коротких пароксизмов к постоянной форме. Артериальная гипертензия (АГ) – наиболее частая причина ФП. Целью настоящего обзора было осветить роль возможных предикторов прогрессирования ФП у пациентов с АГ. Проанализирована роль общих факторов риска в поддержании аритмии, значение повышенного артериального давления и его отдельных характеристик в прогрессировании ФП. Описаны эхокардиографические предикторы рецидива аритмии и перехода ФП в постоянную форму при АГ. Представлены разные существующие шкалы оценки риска прогрессирования ФП. Рассмотрены возможности вторичной профилактики аритмии при АГ.
Литература
Heijman J, Luermans JGLM, Linz D, van Gelder IC, Crijns HJGM. Risk Factors for Atrial Fibrillation Progression. Card Electrophysiol Clin. 2021;13(1):201-209. https://doi.org/10.1016/j.ccep.2020.10.011.
Kisheva A, Yotov Y. Risk factors for recurrence of atrial fibrillation. Anatol J Cardiol. 2021;25(5):338-345. https://doi.org/10.14744/AnatolJCardiol.2020.80914.
Truong CD, Nguyen BT, Van Cong Tran T. Prediction of risk factors for recurrence of atrial fibrillation in patients with arterial hypertension. Int J Cardiovasc Imaging. 2021;37(12):3413-3421. https://doi.org/10.1007/s10554-021-02331-y.
Kamioka M, Hijioka N, Matsumoto Y, Nodera M, Kaneshiro T, Suzuki H, Takeishi Y. Uncontrolled blood pressure affects atrial remodeling and adverse clinical outcome in paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2018;41(4):402-410. https://doi.org/10.1111/pace.13311.
de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC, Allessie MA, Crijns HJ. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010;55(8):725-31. https://doi.org/10.1016/j.jacc.2009.11.040.
Zhao LQ, Liu SW. Atrial fibrillation in essential hypertension: an issue of concern. J Cardiovasc Med (Hagerstown). 2014;15(2):100-106. https://doi.org/10.2459/JCM.0b013e3283640ff7.
Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J, Sheldon R, Dorian P, Newman D. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J. 2005;149(3):489-96. https://doi.org/10.1016/j.ahj.2004.09.053.
Li A, Chen Y, Wang W, Su L, Ling Z. Association of clinical predictors with recurrence of atrial fibrillation after catheter ablation. Ann Noninvasive Electrocardiol. 2020;25(6):e12787. https://doi.org/10.1111/anec.12787.
Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace. 2014;16(2):202-7. https://doi.org/10.1093/europace/eut210.
Kinoshita M, Herges RM, Hodge DO, Lindsay Friedman, Ammash N, Bruce Ch J, Somers V, Malouf J F, Askelin J, Gilles J A, Gersh B J, Friedman P A. Role of smoking in the recurrence of atrial arrhythmias after cardioversion. Am J Cardiol. 2009;104:678-682.
Fukamizu S, Sakurada H, Takano M, Hoj R, Nakai M, Yuba T, Komiyama K, Tatsumoto A, Maeno K, Mizusawa Y, Tanab Y, Suzuki M, Tejima T, Nishizaki M, Kobayashi Y, Hiraoka M. Effect of cigarette smoking on the risk of atrial fibrillation recurrence after pulmonary vein isolation. Journal of Arrhythmia. 2010;26(1):21-29. https://doi.org/10.1016/S1880-4276(10)80032-8.
Tsang TS, Barnes ME, Miyasaka Y, Cha SS, Bailey KR, Verzosa GC, Seward JB, Gersh BJ. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J. 2008;29(18):2227-33. https://doi.org/10.1093/eurheartj/ehn324.
Hidirova LD, Jahontov DA, Zenin SA, Maksimov VN. Nekotorye fenotipicheskie i geneticheskie markery progressirovanija fibrilljacii predserdij na fone arterialnoj gipertonii. In: Tezisy VII Evrazijskogo kongressa kardiologov; 2019 May 17-18; Tashkent. 2019. P 241-242. (Eurasian Heart Journal; suppl 1). edn: OQFMDA (Russian).
Wang X, Hou Y, Wang X, Li Z, Wang X, Li H, Shang L, Zhou J, Zhang Y, Ren M, Zhang Y. Relationship between serum uric acid levels and different types of atrial fibrillation: An updated meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31(10):2756-2765. https://doi.org/10.1016/j.numecd.2021.05.034.
Xu X, Du N, Wang R, Wang Y, Cai S. Hyperuricemia is independently associated with increased risk of atrial fibrillation: A meta-analysis of cohort studies. Int J Cardiol. 2015;184:699-702. https://doi.org/10.1016/j.ijcard.2015.02.038.
Snezhitsky VA, Yatskevich ES, Doroshenko EM, Smirnov VYu, Dolgoshey TS, Rubinsky AYu. Homocysteine as a prognostic marker of atrial remodeling and clinical picture in patients with paroxysmal and persistent forms of atrial fibrillation. Clinical Medicine. Russian journal. 2016;94(1):16-22. https://doi.org/10.18821/0023-2149-2016-94-1-16-22. https://elibrary.ru/vkyatz. (Russian).
Ionin VA, Zaslavskaya EL, Barashkova EI, Pavlova VA, Ananin AM, Morozov AN, Baranova EI. Predictors of atrial fibrillation recurrence in patients with metabolic syndrome after pulmonary vein isolation. Russian Journal of Cardiology. 2022;27(Suppl 3):16-26. https://doi.org/10.15829/1560-4071-2022-5184. https://elibrary.ru/bpoifi (Russian).
Kamioka M, Kaneshiro T, Hijioka N, Amami K, Nodera M, Yamada S, Takeishi Y. Visit-to-Visit Blood Pressure Variability Predicts Atrial Fibrillation Recurrence After Pulmonary Vein Isolation in Patients With Hypertension and Atrial Fibrillation. Circ Rep. 2021;3(4):187-193. https://doi.org/10.1253/circrep.CR-21-0014.
Erküner Ö, Dudink EAMP, Nieuwlaat R, Rienstra M, Van Gelder IC, Camm AJ, Capucci A, Breithardt G, LeHeuzey JY, Lip GYH, Crijns HJGM, Luermans JGLM. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey). Am J Cardiol. 2018;122(4):578-583. https://doi.org/10.1016/j.amjcard.2018.04.053.
Xiang H, Xue Y, Chen Z, Yu Y, Peng Y, Wang J, Ji K, Zhu H. The Association Between Left Ventricular Hypertrophy and the Occurrence and Prognosis of Atrial Fibrillation: A Meta-Analysis. Front Cardiovasc Med. 2021;8:639993. https://doi.org/10.3389/fcvm.2021.639993.
Lau DH, Shenasa HA, Shenasa M. Hypertension, Prehypertension, Hypertensive Heart Disease, and Atrial Fibrillation. Card Electrophysiol Clin. 2021;13(1):37-45. https://doi.org/10.1016/j.ccep.2020.11.009.
Solovev DA. Remodelirovanie levyh otdelov serdca kak prediktor fibrilljacii predserdij u pacientov s metabolicheskim sindromom. In: Sikorskij AV, Doronina OK, Terehova TV, editors. Fundamentalnaja nauka v sovremennoj medicine 2016. Materialy satellitnoj distancionnoj nauchno-prakticheskoj konferencii studentov i molodyh uchjonyh; 2016 March 7, Minsk. Minsk: Belorusskij gosudarstvennyj medicinskij universitet; 2016. p. 276-282. edn: XSVQUV. (Russian).
Bukvalnaya NV, Yakubova LV, Snezhitsky VA. Arterial hypertension and atrial fibrillation: molecular genetic aspects of pathogenesis and complex therapy, focus on the renin-angiotensin-aldosterone system. Emergency Cardiology and Cardiovascular Risks. 2020;4(2):986-993. edn: YXRRHN. (Russian).
Suzuki T, Yamazaki T, Ogawa S, Nagai R, Yamashita T. Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J-RHYTHM II Study). Heart Rhythm. 2011;8(12):1831-1836. https://doi.org/10.1016/j.hrthm.2011.07.035.
Podzolkov VI, Tarzimanova AI. Predictors of progression of atrial fibrillation in patients with arterial hypertension. Systemic Hypertension. 2016;13(1):11-14. edn: VWZXAN. (Russian).
De With RR, Marcos EG, Dudink EAMP, Spronk HM, Crijns HJGM, Rienstra M, Van Gelder IC. Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AFRISK study. Europace. 2020;22(3):352-360. https://doi.org/10.1093/europace/euz339.
Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications. J Am Coll Cardiol. 2015;66(8):943-959. https://doi.org/10.1016/j.jacc.2015.06.1313.PMID:26293766.
Lin X, Wu N, Shi Y, Wang S, Tan K, Shen Y, Dai H, Zhong J. Association between transforming growth factor β1 and atrial fibrillation in essential hypertensive patients. Clin Exp Hypertens. 2015;37(1):82-87. https://doi.org/10.3109/10641963.2014.913600.
Kornej J, Hindricks G, Shoemaker MB, Husser D, Arya A, Sommer P, Rolf S, Saavedra P, Kanagasundram A, Patrick Whalen S, Montgomery J, Ellis CR, Darbar D, Bollmann A. The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation. Clin Res Cardiol. 2015;104(10):871-876. https://doi.org/10.1007/s00392-015-0856-x.
Canpolat U, Aytemir K, Yorgun H, Şahiner L, Kaya EB, Oto A. A proposal for a new scoring system in the prediction of catheter ablation outcomes: promising results from the Turkish Cryoablation Registry. Int J Cardiol. 2013;169(3):201-206. https://doi.org/10.1016/j.ijcard.2013.08.097.
Mesquita J, Ferreira AM, Cavaco D, Moscoso Costa F, Carmo P, Marques H, Morgado F, Mendes M, Adragão P. Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure - ATLAS score. Europace. 2018;20(FI_3):f428-f435. https://doi.org/10.1093/europace/eux265.
Mujović N, Marinković M, Marković N, Shantsila A, Lip GY, Potpara TS. Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score. Sci Rep. 2017;7:40828. https://doi.org/10.1038/srep40828.
Nalliah CJ, Sanders P, Kottkamp H, Kalman JM. The role of obesity in atrial fibrillation. Eur Heart J. 2016;37(20):1565-72. https://doi.org/10.1093/eurheartj/ehv486.
Fauchier L, Clementy N, Babuty D. Statin therapy and atrial fibrillation: systematic review and updated meta analysis of published randomized controlled trials. Curr Opin Cardiol. 2013;28(1):7-18. https://doi.org/10.1097/HCO.0b013e32835b0956.
Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna WP, Sanders P. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222-31. https://doi.org/10.1016/j.jacc.2014.09.028.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrӧm-Lundqvist C, Boriani G, Castella M, Dan G, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau J, Lettino M, Lip GY, Pinto FJ, Neil Thomas G, Valgimigli M, Van Gelder IC, Van Puttel BP, Watkins CL. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Russian Journal of Cardiology. 2021;26(9):234-329. https://doi.org/10.15829/1560-4071-2021-4701 (Russian).
Yildiz M, Oktay AA, Stewart MH, Milani RV, Ventura HO, Lavie CJ 3 Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis. 2020;63(1):10-21. https://doi.org/10.1016/j.pcad.2019.11.009.
Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev. 2019 (9):CD005049. https://doi.org/10.1002/14651858.CD005049.pub5.
Poole JE, Bahnson TD, Monahan KH, Johnson G, Rostami H, Silverstein AP, Al-Khalidi HR, Rosenberg Y, Mark DB, Lee KL, Packer DL. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. J Am Coll Cardiol. 2020;75(25):3105-3118. https://doi.org/10.1016/j.jacc.2020.04.065.
Pokushalov E, Romanov A, Katritsis DG, Artyomenko S, Bayramova S, Losik D, Baranova V, Karaskov A, Steinberg JS. Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience. Heart Rhythm. 2014;11(7):1131-1138. https://doi.org/10.1016/j.hrthm.2014.03.055.
